Education
About Us
Working with TipRanks
Follow Us
Shanghai Henlius Biotech, Inc. Class H (HK:2696)
:2696
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 5.72B | ¥ 5.39B | ¥ 3.21B | ¥ 1.68B | ¥ 587.59M |
| Gross Profit | ¥ 4.18B | ¥ 3.92B | ¥ 2.37B | ¥ 1.16B | ¥ 405.47M |
| Operating Income | ¥ 939.13M | ¥ 631.70M | ¥ -628.53M | ¥ -665.25M | ¥ -924.95M |
| EBITDA | ¥ 1.15B | ¥ 911.33M | ¥ -310.61M | ¥ -671.74M | ¥ -814.06M |
| Net Income | ¥ 820.47M | ¥ 546.02M | ¥ -695.26M | ¥ -984.05M | ¥ -993.54M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 772.96M | ¥ 1.01B | ¥ 680.48M | ¥ 742.32M | ¥ 1.11B |
| Total Assets | ¥ 10.60B | ¥ 9.90B | ¥ 8.92B | ¥ 7.17B | ¥ 6.44B |
| Total Debt | ¥ 3.65B | ¥ 4.09B | ¥ 3.68B | ¥ 2.62B | ¥ 1.83B |
| Net Debt | ¥ 2.88B | ¥ 3.11B | ¥ 3.00B | ¥ 2.47B | ¥ 719.31M |
| Total Liabilities | ¥ 7.58B | ¥ 7.71B | ¥ 7.29B | ¥ 4.88B | ¥ 3.24B |
| Stockholders' Equity | ¥ 3.01B | ¥ 2.19B | ¥ 1.64B | ¥ 2.30B | ¥ 3.20B |
| Cash Flow | |||||
| Free Cash Flow | ¥ 404.68M | ¥ 36.48M | ¥ -383.67M | ¥ -1.04B | ¥ -2.12B |
| Operating Cash Flow | ¥ 1.24B | ¥ 1.05B | ¥ 981.62M | ¥ 90.39M | ¥ -609.58M |
| Investing Cash Flow | ¥ -909.97M | ¥ -1.00B | ¥ -1.36B | ¥ -1.68B | ¥ -1.51B |
| Financing Cash Flow | ¥ -643.37M | ¥ 144.43M | ¥ 858.02M | ¥ 648.30M | ¥ 995.79M |